Recently, we immunized different mammalian species (goats, mice, rats, rabbits, guinea pigs and hamsters) with the recombinant ectodomain of the transmembrane envelope (TM) protein p15E of porcine endogenous retrovirus (PERV). In all cases, neutralizing immune sera were induced, which recognized epitopes in the fusion peptide proximal region and the membrane proximal external region of p15E. In order to analyse whether pigs are also able to produce such antibodies, and whether such antibodies can be used to study the involvement of the TM protein in placental development (as was shown for endogenous retroviruses of other species), German landrace pigs were immunized with PERV p15E. No binding and neutralizing antibodies were produced as shown in three Western blot analyses and in a neutralization assay, indicating that pigs are tolerant to their endogenous retroviruses, at least for the ectodomain of the TM protein.
Porcine endogenous retroviruses (PERVs) are found in the genome of all domestic pigs Le Tissier et al., 1997) . Their expression varies depending on the pig strain and the tissue of the individual animal (Bittmann et al., 2012) . PERVs are released from normal porcine cells, such as PBMCs, after mitogen stimulation (Wilson et al., 1998; Tacke et al., 2003) . As PERV-A and PERV-B, which are present in the genome of all pigs, are able to infect human cells in vitro Wilson et al., 1998; Specke et al., 2001) , they represent a potential risk in the case of porcine cells, tissues and organs being used for xenotransplantation (Wilson, 2008) . Intact PERV-C represents an ecotropic virus that it is not in the genome of all pigs. However, recombination with PERV-A results in highly replication-competent human-tropic PERV-A/C (reviewed by Denner, 2008) . Several strategies have been proposed to avoid transmission of PERV to human recipients, including (i) selection of pigs with low expression of PERV, (ii) the use of PERV-C free pigs, which prevents generation of PERV-A/C, (iii) development of a specific vaccine and (iv) the production of transgenic pigs expressing PERV-specific small interfering RNA to suppress PERV expression (reviewed by Denner & Tönjes, 2012) . For vaccine development, immunization studies with the surface (SU, gp70) and transmembrane envelope (TM, p15E) proteins of PERV were performed, and binding and neutralizing antibodies were obtained (Fiebig et al., 2003; Kaulitz et al., 2011; . Sera obtained by immunization with the ectodomain of the TM protein p15E recognized epitopes in the fusion peptide proximal region and in the membrane proximal region (MPER). This pattern was observed after immunization of goats, mice, rats, rabbits, guinea pigs and hamsters; however, information for domestic pigs is missing. Interestingly, one epitope recognized in the MPER of p15E (GWFEGWFNR) is similarly located near the viral membrane and has limited sequence homology with an epitope in the TM protein gp41 of human immunodeficiency virus type 1 (HIV-1) (NWFNIT, identical amino acids in bold), recognized by the 4E10 antibody and broadly neutralizing HIV-1 (Zwick et al., 2001) (Table S1 , available in the online Supplementary Material). We have shown that only antibodies directed specifically against the MPER of PERV p15E are crucial for neutralization (Waechter et al., 2013) . Here, we asked the question of whether pigs produce a similar antibody response to that shown in the species tested so far. This experiment was also set up to develop a tool that could be used to study the role of TM protein p15E during pregnancy. In many species, envelope proteins of endogenous retroviruses (also called syncytins) are involved in placentogenesis, mainly contributing to fusion of the syncytiotrophoblast (reviewed by Lavialle et al., 2013) . In addition, two of the TM proteins expressed in the human placenta are immunosuppressive (Mangeney et al., 2007; Kämmerer et al., 2011; Morozov et al., 2013) and may thus also contribute to a successful pregnancy. The corresponding porcine TM proteins/syncytins are still unknown.
as a calmodulin-binding protein (CBP) fusion protein in Escherichia coli BL21 and purified by CBP affinity chromatography as described previously (Kaulitz et al., 2011) (Fig. 1b) . Three female German landrace pigs (1 year old, 160 kg, from the experimental farm of the Institute of Farm Animal Genetics, Mariensee, Germany) were immunized seven times with 22-day intervals intramuscularly closely behind the ear (Fig. 1c) . Two animals received 500 mg p15E in Freund's adjuvant (animals #785 and # 828), and one animal received adjuvant with PBS only (animal #825). For the first immunization, complete Freund's adjuvant was used, and for all others incomplete adjuvant was used. Immediately prior to immunization, pre-immune serum was taken. Pre-immune and immune sera after each immunization were tested for binding antibodies using Western blot analysis using recombinant CBP-p15E produced in E. coli (the same as that used for immunization) and using purified virus as antigen. The virus was obtained from cell-free supernatants of the human embryonic kidney 293 (HEK293) cell line producing a recombinant PERV-A/C that had been repeatedly passaged on human cells. PERV-A/C is characterized by genetic alterations in its long terminal repeats Karlas et al., 2010) . After removal of the cells by centrifugation at 1200 g for 10 min and at 4000 g for 15 min, the supernatants were filtered through 0.45 mm filters (Millipore), and centrifuged at 28000 r.p.m. (SW32Ti rotor; Beckman) for 2 h. The pellet was resuspended in PBS and centrifuged through a 20 % sucrose cushion at 36000 r.p.m. (SW 50.1Ti rotor; Beckman) for 2 h. In addition, CBP-p15E was cleaved by thrombin [0.03 U (10 mg protein)
21
, 24 h, 21 u C; Novagen]. Western blot analyses were performed as described previously (Kaulitz et al., 2011) . Goat sera obtained by immunization with p15E (animal #346), p27
Gag (animal #30) and gp70 (animal #62) of PERV were used as positive controls. Rabbit anti-pig serum (Antibodies Online) and rabbit anti-goat serum (Dako) labelled with HRP were used for ECL detection. Antibodies against the recombinant p15E were not found in sera of animals immunized with the ectodomain of p15E (animals # 785 and # 828) (Fig. 2 shows the results obtained with sera from animal #828; similar results were obtained with sera from animal #785). The immune sera recognized other proteins, possibly bacterial contaminations of the recombinant antigen used in the Western blot. The same antigen preparation containing minor bacterial contaminations was used for immunization. This might explain why the response against the bacterial proteins increased over time, which showed that the pigs were immunized correctly (i.e. the injections were set correctly without technical fault) and that the animals were immune competent (Fig. 2a, b) . The animal immunized with adjuvant alone (#825) did not -as expected -produce antibodies against p15E. To avoid perturbations by the bacterial contamination, Western blot analyses were performed with highly purified virus. No p15E-specific antibodies were found, although the control sera demonstrated the presence of p15E, gp70 and p27
Gag in the virus preparation (Fig. 2c, d ). In addition, when the CBP-p15E fusion protein cleaved by thrombin was used in Western blot analyses, the absence of antibodies against p15E was confirmed (Fig. S1) . Interestingly, there were also no antibodies against CBP, which was expected, as this protein is highly conserved among different species.
Although no binding antibodies were detected, neutralizing antibodies may have been induced binding to conformational domains of p15E not detectable when the proteins were linearized in SDS-PAGE and Western blot analyses. A neutralization assay was performed as described elsewhere (Kaulitz et al., 2011) with minor modifications. Briefly, HEK293 cells (3610 4 cells per well) were seeded a day before, decomplemented sera from pigs #825, #785 and #828 as well as a neutralizing goat serum (#355) were mixed with a defined dilution of PERV/5 u , a virus adapted to growth on human cells , and added after 30 min incubation at 37 u C to the cells. After 4 days of incubation, the cells were lysed by freeze-thawing and addition of lysis buffer containing 0.2 mg proteinase K ml
. Lysate (3 ml) was investigated in a real-time PCR using probes and primers for the gag gene of PERV and human glyceraldehyde 3-phosphate dehydrogenase as described previously (Kaulitz et al., 2011) . Neutralization was estimated as the increase in cycle threshold value compared with cells incubated with virus alone. No neutralizing antibodies were detected in the pig sera, but the goat serum against p15E showed efficient neutralization (Fig. S2) .
The findings can be explained in various ways. First, the animals may have been tolerant; and secondly, detection of antibodies may have been hampered by interactions between antigen and antibody resulting in immune complexes in blood or in organs where the virus proteins may be expressed. Two different methods were used to analyse whether immune complexes were present in serum. First, sera were diluted either 1 : 3 in PBS (non-dissociated samples) or 1 : 2 in dissociation buffer (1.5 M glycine, pH 2.8), followed by incubation for 1 h at 37 u C. The reaction was stopped by addition of 1 vol. neutralization buffer (1.5 M Tris/HCl, pH 9.7) to achieve an end dilution of 1 : 3 for the sample. The sera were added immediately to the blot (Koraka et al., 2003) . No specific antibodies for the recombinant p15E were found in treated serum, suggesting that there were no complexes (Fig. 2) . The same result was obtained when viral lysates were used as antigen (Fig. 2) . Fig.  2 shows the results obtained with sera from animal #828; similar results were obtained with sera from animal #785. Secondly, SDS-PAGE was performed with sera from immunized and non-immunized pigs, which were then blotted and developed with antisera directed against the ectodomain of p15E, p27
Gag and gp70 (rp52) of PERV (Kaulitz et al., 2011) . The sera against p15E, p27 and gp70 detected the recombinant and viral proteins, used as controls, but did not detect viral antigens in the serum batches (data not shown). Both methods excluded the presence of immune complexes in the sera, but we cannot exclude the possibility that antibodies are adsorbed on p15E expressed in tissues. However, this seems unlikely, especially as the animals were healthy.
These findings indicated that normal German landrace pigs did not produce antibodies against PERV p15E upon repeated immunization, even when using a strong adjuvant. In contrast to our observation in pigs, antibodies against endogenous retroviruses have been described in cats, humans and mice. The most convincing example for antibody production against endogenous retroviruses in a host species is the antibody response against the human endogenous retrovirus HERV-K in humans. Antibodies against HERV-K, particularly against the TM protein, were found in the sera of patients with germ cell tumours and melanomas and in some Immunization of pigs with PERV pregnant women, correlating with the expression of HERV-K in these tumours, as well as in the placenta (Muster et al., 2003; Büscher et al., 2005 Büscher et al., , 2006 Löwer et al., 1996) . Possibly, the endogenous retroviral sequences were never expressed in humans during ontogenesis, which facilitates antibody production. In pigs, PERVs might be expressed at a certain stage of development, leading to classification of the endogenous retroviruses as 'self antigen'. When cats were immunized with p15E of feline leukemia virus (FeLV), which is closely related to PERV, binding and neutralizing antibodies were found in sera of all animals, even though the feline genome contains retroviral sequences related to the p15E sequence used for immunization (Langhammer et al., 2006 (Langhammer et al., , 2011b , especially in the epitope region (Table S1 ), suggesting that cats are not tolerant against their endogenous retroviruses. The induced neutralizing antibodies were even protective in vivo when cats were challenged with infectious FeLV (Langhammer et al., 2011a) . The immune response and the epitopes recognized were similar in cats and the other species (Langhammer et al., 2005 (Langhammer et al., , 2006 (Langhammer et al., , 2011a (Langhammer et al., , 2011b . The situation in mice, which are often characterized by strong expression of their endogenous retroviruses, is as complicated as in cats. Whereas young mice appear to be tolerant (Ihle & Hanna, 1977; Huebner et al., 1971) , older animals and some mouse strains develop antibodies against all viral proteins (Oldstone et al., 1972 (Oldstone et al., , 1976 Hanna et al., 1975; Ihle et al., 1973) . In some cases, the antibodies were trapped together with the corresponding viral antigen in the kidney of the animals, causing glomerulonephritis (Huebner et al., 1971; Oldstone et al., 1976) . The mechanism by which the immune system produces antibodies against endogenous retroviruses in mice is still unknown. Expression of infectious or non-infectious recombinant polytropic viruses after the establishment of immunological tolerance to endogenous retroviral antigens that are expressed earlier in life may play some role in escape from tolerance and in stimulating the immune system (Miyazawa & Fujisawa, 1994) . This may be also a mechanism in cats.
To summarize, to our knowledge this is the first report demonstrating that pigs are tolerant against the TM protein p15E of PERVs. In contrast, humans, cats and mice are able to produce antibodies against their endogenous retroviruses. Koalas are another species unable to produce antibodies against their endogenous retroviruses (KoRVs). When we investigated sera from animals infected with KoRV-A and KoRV-B no antibodies against viral proteins were detected (unpublished data).
As we were unable to induce antibodies against PERV p15E, we cannot use them as a tool for studying the role of p15E during pregnancy.
